This thesis includes three main contributions. The first chapter, an article published in 2019 in the Revue Française d'Économie n°2/vol XXXIV", provides a literature review on the implications of genetic testing regulations on the health insurance market. We show that the choice of a...

The scope and ambitions of biomedical institutions worldwide currently working toward the integration of personalized medicine (PM) require recognizing the potential profound impact on regulatory standards and on the economic functioning and financing of healthcare. Against this background,...

We compare two genetic testing regulations, Disclosure Duty (DD) and Consent Law (CL), in an environment where individuals choose to take a genetic test or not. DD forces agents to reveal the test results to their insurers, resulting in a discrimination risk. CL allows agents to withhold that...